Liang Zhou
About Liang Zhou
Liang Zhou is a Scientist III at Asklepios BioPharmaceutical, Inc. with expertise in oncology and immunofluorescence techniques, having previously held academic positions at Virginia Commonwealth University for over six years.
Current Role at Asklepios BioPharmaceutical
Liang Zhou currently holds the position of Scientist III at Asklepios BioPharmaceutical, Inc. (AskBio) in Raleigh, North Carolina. In this role, Zhou applies expertise in oncology and advanced laboratory techniques to contribute to the company's research and development efforts. Zhou has been with AskBio since 2022, bringing a strong background in cellular and molecular biology to the team.
Previous Experience at Virginia Commonwealth University
Prior to joining Asklepios BioPharmaceutical, Liang Zhou worked at Virginia Commonwealth University (VCU) for a total of seven years. Zhou served as an Instructor from 2018 to 2022, where responsibilities included teaching and mentoring students. Before that, Zhou held positions as a Postdoctoral Research Associate from 2012 to 2018 and as a Postdoctoral Scholar from 2011 to 2012. These roles involved conducting research in the Richmond, Virginia area, focusing on various aspects of cellular biology.
Educational Background
Liang Zhou has a robust educational background in the life sciences. Zhou earned a Doctor of Philosophy (PhD) in Cell/Cellular and Molecular Biology from Northeast Normal University, completing the program from 2005 to 2010. Additionally, Zhou holds a Doctor of Medicine (MD) degree from Jilin University, where studies were completed from 1999 to 2004, focusing on Clinical Medicine. This combination of degrees supports Zhou's expertise in oncology and related research fields.
Skills and Expertise
Liang Zhou possesses strong skills in oncology, which are complemented by expertise in various laboratory techniques. Notably, Zhou is proficient in immunofluorescence and ELISA techniques, essential for conducting research in cellular and molecular biology. These skills enhance Zhou's contributions to ongoing projects at Asklepios BioPharmaceutical and reflect a commitment to advancing scientific knowledge in the field.